intermittent and continuous injections of oxytocin in the active phase on maternal and fetal outcomes in induction of labor

comparison the intermittent and continuous injections of oxytocin in the active phase on maternal and fetal outcomes in induction of labor

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230221057483N1

Enrollment

140

Registered

2023-04-30

Start date

2023-04-19

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delivery. Preterm labor with preterm delivery, unspecified trimester, other fetus

Interventions

Intervention 1: Intervention group:Oxytocin will continue at the same dose until delivery. Intervention 2: Control group: Oxytocin is stopped and serum will be used for injection.

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Pregnant women with a live fetus indication of induction of labor at 36 to 42 weeks Pregnant women of one term and gravid

Exclusion criteria

Exclusion criteria: History of uterine surgery Fetus with congenital malformation and IUFD Irregular fetal heart pattern Pre-eclampsia Detachment of the placenta as a primary diagnosis ROM The presence of a placenta or suspicion of placental detachment Presence of intrauterine growth retardation Improper progress in the birth process and position of the fetus

Design outcomes

Primary

Measure	Time frame
Episiotomy. Timepoint: During delivery and after delivery. Method of measurement: Obstetrician and gynecologist examination.;Fever. Timepoint: Postpartum. Method of measurement: Digital thermometer.;Postpartum hemorrhage. Timepoint: patient's vital signs and CBC. Method of measurement: test results and patient symptoms.;Caesarean delivery. Timepoint: delivery time. Method of measurement: Obstetrician and gynecologist examination.;Perineal trauma. Timepoint: During delivery and after delivery. Method of measurement: Obstetrician and gynecologist examination.;Chorioamnionitis. Timepoint: delivery time. Method of measurement: Patient's vital signs and thermometer.;Cervical rupture. Timepoint: delivery time. Method of measurement: Obstetrician and gynecologist examination.	—

Measure

Time frame

Episiotomy. Timepoint: During delivery and after delivery. Method of measurement: Obstetrician and gynecologist examination.;Fever. Timepoint: Postpartum. Method of measurement: Digital thermometer.;Postpartum hemorrhage. Timepoint: patient's vital signs and CBC. Method of measurement: test results and patient symptoms.;Caesarean delivery. Timepoint: delivery time. Method of measurement: Obstetrician and gynecologist examination.;Perineal trauma. Timepoint: During delivery and after delivery. Method of measurement: Obstetrician and gynecologist examination.;Chorioamnionitis. Timepoint: delivery time. Method of measurement: Patient's vital signs and thermometer.;Cervical rupture. Timepoint: delivery time. Method of measurement: Obstetrician and gynecologist examination.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarinaz Karimi

Sanandaj University of Medical Sciences

farinazka1369@gmail.com+98 87 6633 5346

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026